advisory council

ASAP is advised by active researchers and experts in Parkinson's disease and neurodegenerative diseases from around the world. Our advisors include representatives from academia, government, nonprofits and industry.

Rat Embryonic Nerve Cells Photo Credit: Laura Struzyna, Cullen Laboratory, Perelman School of Medicine, University of Pennsylvania
James Beck, PhD

James Beck, PhD

Parkinson's Foundation

Patrik Brundin, MD, PhD

Patrik Brundin, MD, PhD

Van Andel Research Institute Center for Neurodegenerative Science

Pietro De Camilli, MD

Pietro De Camilli, MD

Kavli Institute for Neuroscience at Yale School of Medicine

Marie-Françoise Chesselet, MD, PhD

Marie-Françoise Chesselet, MD, PhD

David Geffen School of Medicine at UCLA

Martin Citron, PhD

Martin Citron, PhD

UCB Pharma

David Dexter, PhD

David Dexter, PhD

Parkinson’s UK, Imperial College London

Ted Dawson, MD, PhD

Ted Dawson, MD, PhD

Johns Hopkins University School of Medicine

Thomas Gasser, MD, PhD

Thomas Gasser, MD, PhD

Hertie Institute for Clinical Brain Research

Magali Haas, MD, PhD

Magali Haas, MD, PhD

Cohen Veterans Bioscience

Karl Kieburtz, MD, MPH

Karl Kieburtz, MD, MPH

University of Rochester Medical Center

Walter Koroshetz, MD

Walter Koroshetz, MD

Federal Liaison to the Council

National Institute of Neurological Disease and Stroke

Robert Malenka, MD, PhD

Robert Malenka, MD, PhD

Stanford University School of Medicine

Kelsey Martin, MD, PhD

Kelsey Martin, MD, PhD

David Geffen School of Medicine at UCLA

Eliezer Masliah, MD

Eliezer Masliah, MD

Federal Liaison to the Council

National Institute of Aging, NIH

K. Kimberly McCleary

K. Kimberly McCleary

FasterCures, a Center of the Milken Institute

Karoly Nikolich, PhD

Karoly Nikolich, PhD

Alkahest

C. Warren Olanow, MD

C. Warren Olanow, MD

Mt. Sinai School of Medicine

Bernardo Sabatini, MD, PhD

Bernardo Sabatini, MD, PhD

Harvard Medical School

Randy W. Schekman, PhD

Randy W. Schekman, PhD

Advisory Council Chair

University of California, Berkeley

Darryle Schoepp, PhD

Darryle Schoepp, PhD

Merck

Todd Sherer, PhD

Todd Sherer, PhD

Michael J. Fox Foundation for Parkinson's Research

Andrew Singleton, PhD

Andrew Singleton, PhD

National Institute of Aging, NIH

Beth Stevens, PhD

Beth Stevens, PhD

Harvard Medical School

David Sulzer, PhD

David Sulzer, PhD

Columbia University Medical Center

Huda Zoghbi, MD

Huda Zoghbi, MD

Baylor College of Medicine

catalyst + organizer

ASAP is a joint project of the Sergey Brin Family Foundation and the Milken Institute Center for Strategic Philanthropy that will develop an approach to Parkinson's disease basic research for the next decade.

Purkinje Neurons

The Milken Institute Center for Strategic Philanthropy (MICSP) believes that philanthropy has the opportunity to take on big risks to test bold ideas. We conduct deep due diligence across a range of issue areas, promote creative and well-informed giving strategies and advise families and foundations on where and how to channel their philanthropy.

Learn more

ASAP, created with the support of the Sergey Brin Family Foundation, will apply this strategic approach to accelerate basic research in Parkinson's disease. We welcome researchers, patients and funders to help identify the most relevant scientific questions in Parkinson's disease and develop a roadmap to address them. By advancing our understanding of how Parkinson's disease originates and progresses, ASAP will spur the development of more effective treatments.